Madhuri Bewtra, MD
Obstetrics & Gynecology · Englewood, NJNPI 1447358700
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,050 of the $4,805 with a category attached, or 84.3%. Celularity Inc. accounts for 86.0% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2021 at $1,415 and has fallen 83.8% since, to $229 in 2025. Among obstetrics & gynecology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $80.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Celularity Inc.$4K
- Hologic Sales And Service, LLC$98
- Mayne Pharma Commercial LLC$85
- Exeltis, USA Inc.$75
- AbbVie$75
- Avion Pharmaceuticals$66
- plus $272 from 10 others
What the payments were for
- Speaking & faculty fees$4,05084%
- Food & beverage$75516%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Celularity Inc. | 19 | $4,134 |
| Hologic Sales And Service, LLC | 3 | $98 |
| Mayne Pharma Commercial LLC | 5 | $85 |
| Exeltis, USA Inc. | 5 | $75 |
| AbbVie | 6 | $75 |
| Avion Pharmaceuticals | 5 | $66 |
| Astellas Pharma US Inc | 2 | $40 |
| Pfizer | 2 | $34 |
| Dysis Medical, Inc. | 2 | $31 |
| Coopersurgical, Inc. | 2 | $30 |
| Therapeuticsmd, Inc. | 2 | $30 |
| Millicent US Inc | 2 | $27 |
| Bayer | 1 | $25 |
| Merck | 2 | $24 |
| Evofem Biosciences, Inc. | 1 | $16 |
| Agile Therapeutics, Inc. | 1 | $15 |
How this compares
$4,805 in reported general payments places this provider in the 90th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 16 | $2,309 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Englewood
- Jennifer AshtonEnglewood$1.5M
- Yitzhack AsulinEnglewood$11K
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Paula JasionowskiVoorhees$193K
- Justin ChuraSwedesboro$179K
- Andrea VentolaFlorham Park$145K
- Aiman ShiladPaterson$100K
- Patrick CulliganMorristown$93K
- Dipak DelvadiaCherry Hill$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.